RNAZ

Transcode Therapeutics Inc (RNAZ)

US
$ 0.38-5%

Price Chart

Key Statistics

Market Cap
$ 5.81M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
6.98M
52W High
$ 1034.88
52W Low
$ 6.15
Dividend Yield
0.00%
Beta
1.33

Technicals

50-Day MA
9.3696
200-Day MA
197.2207
52 Week High
1034.88
52 Week Low
6.1488

About RNAZ

TransCode Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing drugs and diagnostics for treating and identifying cancer.

Employees
7
Headquarters
Boston, MA
CEO
Dr. Philippe P. Calais Ph.D., Pharm., Pharm.D.

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
RDDT
Reddit Inc. Class A...
$ 132.60
5.04
BBWI
Bath & Body Works I...
$ 27.07
4.84
CLF
Cleveland-Cliffs In...
$ 7.65
4.22
HP
Helmerich & Payne I...
$ 18.65
3.32
AG
First Majestic Silv...
$ 8.56
3.26

Top Losers

Symbol/Name
LTP
% Chg
UAVS
AgEagle Aerial Syst...
$ 1.29
-15.69
ANET
Arista Networks Inc...
$ 89.52
-5.83
JKS
JinkoSolar Holding ...
$ 19.01
-5.38
DAL
Delta Air Lines Inc...
$ 47.00
-5.03
LEN
Lennar Corporation ...
$ 103.91
-5.03